LRRK2 and Parkinson disease: In search of a penetrance biomarker for LRRK2-associated PD, it was found that nonmanifesting LRRK2 mutation carriers had significantly higher levels of urate, an antioxidant, transcription factor Nrf2 activator, and inverse risk factor for idiopathic PD, than those who developed PD [10].